Aemetis Sees Unusually High Options Volume (NASDAQ:AMTX)

Aemetis, Inc (NASDAQ:AMTX) was the target of some unusual options trading on Tuesday. Investors bought 5,962 call options on the stock. This is an increase of approximately 556% compared to the average volume of 909 call options.

Aemetis Stock Up 5.2%

NASDAQ:AMTX traded up $0.08 during trading hours on Tuesday, hitting $1.53. 409,950 shares of the stock were exchanged, compared to its average volume of 754,375. The company has a market capitalization of $100.96 million, a P/E ratio of -0.94 and a beta of 2.31. The company’s 50 day moving average is $1.53 and its two-hundred day moving average is $2.19. Aemetis has a twelve month low of $1.22 and a twelve month high of $3.66.

Aemetis (NASDAQ:AMTX) last issued its quarterly earnings results on Friday, November 7th. The specialty chemicals company reported ($0.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by ($0.12). The firm had revenue of $59.19 million during the quarter, compared to analyst estimates of $87.79 million. On average, equities research analysts expect that Aemetis will post -2.07 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on AMTX shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aemetis in a report on Wednesday, January 21st. Ascendiant Capital Markets decreased their price objective on shares of Aemetis from $21.00 to $20.00 and set a “buy” rating on the stock in a research note on Wednesday, November 19th. Three analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $17.00.

Hedge Funds Weigh In On Aemetis

Several large investors have recently bought and sold shares of the business. Vanguard Group Inc. raised its holdings in shares of Aemetis by 15.3% during the third quarter. Vanguard Group Inc. now owns 2,479,163 shares of the specialty chemicals company’s stock worth $5,578,000 after acquiring an additional 329,760 shares during the period. Jane Street Group LLC acquired a new position in shares of Aemetis during the 2nd quarter worth approximately $634,000. CIBC Bancorp USA Inc. bought a new stake in Aemetis in the 3rd quarter valued at $563,000. Goldman Sachs Group Inc. lifted its holdings in Aemetis by 71.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 218,404 shares of the specialty chemicals company’s stock valued at $380,000 after purchasing an additional 91,367 shares during the last quarter. Finally, GSA Capital Partners LLP lifted its holdings in Aemetis by 42.4% during the 3rd quarter. GSA Capital Partners LLP now owns 179,790 shares of the specialty chemicals company’s stock valued at $405,000 after purchasing an additional 53,508 shares during the last quarter. 27.02% of the stock is currently owned by institutional investors and hedge funds.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.